The low efficiency of conventional therapies in achieving long-term survival of lung cancer patients calls for development of novel options. Revisiting of aerosol gene delivery may provide an alternative for safe and effective treatment for lung cancer. In this study, imidazole ring-containing urocanic acid-modified chitosan (UAC) designed in the previous study was used as a gene carrier. The potential effects of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) on Akt-related signals and cell cycle regulation were evaluated. Aerosols of UAC-PTEN were delivered into K-ras LA1 lung cancer model mice through the nose-only inhalation system twice a week for total 4 weeks. Delivered PTEN suppressed lung tumor development significantly through nuclear complex formation between PTEN and p53, suppressing Akt-related signals as well as cell cycle regulation. Together, our results suggest that aerosol delivery of UAC-PTEN may be compatible with noninvasive in vivo gene therapy.
Introduction
Many efforts have been invested in the field of pulmonary medicine in the hopes of finding feasible therapeutic approaches for diverse lung diseases including cancer because lung is a highly accessible organ for topical application of gene delivery system. [1] [2] [3] Different approaches for gene delivery to the lung such as intravenous injection and nasal or intratracheal instillation have been reported in various animal models. 4, 5 However, these strategies are invasive or the methods may not be suitable for effective delivery of the gene-of-interest throughout pulmonary tissues.
Viral and nonviral vectors have been utilized for gene therapy. Viral vectors are mainly used because of their intrinsic ability to enter cells and promote expression of the gene-of-interest. However, many factors such as induction of an immune response against repeated administration, and difficulties in a large scale production may limit the practical use of viral vectors. 6 On the other hand, nonviral vectors continue to attract a great deal of interest because of several advantages, such as easy manipulation, low cost, safety and a relative nonimmunogenicity. A variety of nonviral vectors have been developed for delivering genes to various organs. Aerosol delivery can deliver the gene-of-interest effectively and is a noninvasive alternative for the targeting of genes to the lungs. 7 In these regards, we have already shown that urocanic acid (UA)-modified chitosan (UAC) is an effective delivery vehicle due to degradability, ability to form a complex with DNA and its physicochemical properties as a gene delivery system with little toxicity and enhanced gene transfection efficiency. 8, 9 Approximately 30% of human tumors carry ras gene mutations. Of the three members of ras family-K-ras, N-ras and H-ras-K-ras are found to be the most frequently mutated members in human tumors, including lung adenocarcinomas (25-50%). 10 In K-ras LA1 mice, the K-ras allele can be activated by in vivo spontaneous recombination event, thus, K-ras LA1 null mice carrying these mutations are highly predisposed to development of various tumor types, and show predominantly early onset of lung cancer that is similar to human non-small cell lung cancer.
11
Almost 70% of non-small cell lung tumors have been noted to show a reduction and loss of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) protein expression.
12 PTEN catalyzes the dephosphorylation of phosphatidylinositol (3,4,5)-triphosphate, specifically at position 3 on the inositol ring, 13 thus, downregulates the Akt signaling pathway, thereby modulating cell growth and survival, and acts as a tumor suppressor gene.
14 Several lines of evidence suggest that Akt is generally activated in tumor cells through the activation of growth factor receptors of Ras, or inactivation of PTEN. 15 A recent report indicated that approximately 90% of non-small cell lung cancer was associated with constitutive activation of the PI3K-Akt pathway, and the activation of Akt promoted cellular survival and resistance to chemotherapy or g-irradiation.
16 Furthermore, K-ras mutation could enhance the motility of lung adenocarcinoma cells by Akt activation. 17 Therefore, regulation of Akt signaling may provide a target for the treatment of lung cancer in the K-ras LA1 model. Here, we report that repeated aerosol delivery of UAC-PTEN complex can significantly suppress pulmonary tumorigenesis in the lungs of K-ras LA1 mice through altering Akt-related signals. Our results support the possibility that UAC carrier may serve as an effective carrier, and that aerosol delivery of PTEN tumor suppressor gene may be a promising approach for lung cancer treatment and prevention in the future.
Materials and methods

Materials
Water-soluble chitosan (molecular weight 100 kDa, 80% degree of deacetylation) was kindly donated by Prof Nah (Sunchon National University, Sunchon, Korea), and free amine chitosan was prepared as previously described. 9 Monoclonal antibodies against Akt1 and phospho-Akt at Thr308 were produced using a general method described elsewhere. Anti-phospho-Akt at Ser473, anti-mTOR antibodies were obtained from Cell Signaling Technology (Beverly, MA), and other antibodies for western blot and immunohistochemistry (IHC) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). pcDNA3.1-green fluorescent protein was purchased from Invitrogen (Carlsbad, CA), and pcDNA3.0-PTEN was kindly gifted by Prof Whang (UNC at Chapel Hill, NC).
Preparation of UAC and UAC-DNA complex UAC was prepared as previously described. 8, 9 Briefly, chitosan was coupled with UA (70 mol %) via an active ester intermediate using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (Peptide Institute, Osaka, Japan). The free amino groups of UAC were determined by ninhydrin assay using glucosamine standard, and the composition of UAC was verified by nuclear magnetic resonance spectroscopy (600 MHz, Bruker BioSpin, Munchen, Germany). With careful and extensive preliminary studies, UAC-DNA complexes at charge ratio 30 were chosen for the most efficient condition of aerosol gene delivery. At the charge ratio, self-assembled UAC-DNA complexes were initiated in distilled water by mixing 1 mg of DNA plasmid with UAC in a drop-bydrop manner under gentle vortex, and the final volume was adjusted to 50 ml. Then, the complexes were incubated at room temperature for 30 min before use.
In vivo aerosol delivery of UAC-PTEN complexes Experiments were carried out on 8-week-old male K-ras LA1 mice. The breeding mice were obtained from Human Cancer Consortium-NCI (Frederick, MD) and kept in our laboratory animal facility with temperature maintained at 23 ± 2 1C, with a relative humidity of 50±20% and a 12-h light-dark cycle. All methods used in this study were approved by the Animal Care and Use Committee at Seoul National University (SNU-060804-5). For gene delivery, mice were placed in nose-only exposure chamber and exposed to the aerosol based on the methods used previously. 8, 18 For the effects of PTEN against lung cancer development, the K-ras LA1 mice were divided into three groups (three mice per group). Control group was not treated with anything and other two groups were exposed to aerosol containing UAC with PTEN expression vector pcDNA3.0-PTEN (PTEN-treated group) or pcDNA3.0 vector alone (vector control), respectively. The K-ras LA1 mice were exposed to aerosols twice a week for total 4 weeks. At the end of the study, K-ras LA1 mice were killed, and the lungs were collected. During the autopsy procedure, the lesions were counted carefully on the surfaces of lungs under microscope. Simultaneously, the lungs were perfused and fixed in 10% neutral-buffered formalin for histopathological examination and IHC. Also, remaining lungs were stored at À70 1C for further study.
Separation of nucleus and cytosol
Nucleus and cytosol were separated by Nuclear Extract Kit from Active Motif (Carlsbad, CA). The lung was weighed and diced into very small pieces using a clean razor blade. Then, the tissues were homogenized thoroughly using by ice-cold 1 Â hypotonic buffer with dithiothreitol and detergent. After incubation for 15 min under ice condition, cytosolic fraction and nuclear pellet were separated by centrifugation at 850 g at 4 1C for 10 min. The supernatant fraction was saved at À80 1C until further use. The nuclear pellet was resuspended in lysis buffer and incubated for 30 min on ice on a rocking platform at 150 rpm. After centrifugation, supernatant containing nuclear proteins was collected for further analysis. 
Western blot analysis
After measuring the protein concentration of the homogenized lysates using a Bradford kit (Bio-Rad, Hercules, CA), equal amounts (50 mg) of protein sample were separated on SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blocked for 1 hr in TBST (Tris-buffered saline þ Tween 20) containing 5% skim milk; immunoblotting was performed by incubating the membranes overnight with their corresponding primary antibodies at 4 1C. After washing in TBST, the membranes were incubated with a horseradish peroxidase (HRP)-labeled secondary antibody and the bands-ofinterest were detected using a luminescent image analyzer, LAS-3000 (Fujifilm, Japan). Results were quantified using Multi Gauge version 2.02 program of the LAS-3000.
Immunohistochemistry
Formalin-fixed, paraffin-embedded tissue sections (5 mm) were mounted on plus slides (Fisher Scientific, Pittsburgh, PA). The tissue sections were deparaffinized in xylene and rehydrated through alcohol gradients and incubated in 200 ml of proteinase K, then washed and incubated in 3% hydrogen peroxide (AppliChem, Darmstadt, Germany) in methanol for 30 min to quench endogenous peroxidase activity. After washing in phosphate-buffered saline (PBS), the tissue sections were incubated with 5% bovine serum albumin in PBS for 1 h at room temperature to block unspecific binding sites. Primary antibodies were applied on the tissue sections overnight at 4 1C. The following day, the tissue sections were washed and incubated with secondary HRP-conjugated antibodies for 1 h at room temperature. After washing, 3,3 0 -diaminobenzidine solution (0.05% 3,3 0 -diaminobenzidine tetrahydrochloride (DAB; Biosesang, Sungnam, Korea) and 0.03% hydrogen peroxide) was applied for 5-10 min, and the tissue sections were counterstained with Mayer's hematoxylin (Dako, Caepinteria, CA). Coverslips were mounted using Permount (Fisher), and the slides were reviewed using a light microscope. Proliferating cell nuclear antigen (PCNA)-positive staining was measured by counting 10 randomly chosen fields per section for the determination of the percentage of DAB-positive cells per 100 cells at magnification Â 400.
Data analysis
Quantification of western blot analysis was performed using Multi Gauge version 2.02. program (Fujifilm). All results are given as means ± s.e.m. The results were analyzed by Student's t-test (Graphpad software, San Diego, CA). *Po0.05 was considered significant and **Po0.01 highly significant compared to corresponding control. 
Results
Repeated aerosol delivery of UAC-PTEN suppressed lung tumorigenesis in K-ras LA1 mice Since we were interested in the effects of repeated aerosol delivery of UAC-PTEN complex, extensive histopathological examinations were performed on the lungs of K-ras LA1 mice. As shown in Figure 1a , aerosol delivery of PTEN twice a week for a month suppressed lung cancer mass significantly (arrows and white dotted circles). Such suppression of lung tumor formation was further confirmed by histopathological examination (Figure 1b) . The nodules developed in the lungs of K-ras LA1 mouse control group (CON) and vector control group (VEC) were in general alveolar/bronchiolar adenoma. However, 
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H Jin et al such tumor development was significantly suppressed in the PTEN-treated lungs (PTEN) of K-ras LA1 mice (arrows and black dotted circle) in which alveolar epithelial cell hyperplasia was usual (Figure 1b) . Such pattern of UAC-PTEN delivery-mediated lung tumor suppression is summarized in Table 1 . As summarized, aerosol-delivered PTEN suppressed tumor numbers as well as adenoma, and hyperplasia incidences significantly.
Repeated aerosol delivery of UAC-PTENPTEN suppressed proteins important for Akt activity in the lungs of K-ras LA1 mice Since PTEN acts as a tumor suppressor gene by suppressing Akt activity, 14 potential effects of repeated aerosol delivery of PTEN were measured by western blot analysis. Repeated aerosol PTEN delivery significantly increased the PTEN protein expression (Figures 2a and  b) . Simultaneously, UAC-mediated PTEN delivery inhibited pulmonary Akt activity significantly through selective suppression of Akt phosphorylation at Ser473. However, total Akt and Akt phosphorylation at Thr308 remained unchanged (Figures 2a and b) .
Repeated aerosol PTEN delivery regulated Akt downstream signaling in the lung of K-ras LA1 mice In this study, we investigated the changes in protein expression of Akt downstream pathway such as mammalian target of rapamycin (mTOR), the p70-kDa ribosomal protein S6 kinase (p70S6K), and eukaryotic initiation factor 4E binding protein 1 (4E-BP1). Our result showed that aerosol delivery of PTEN significantly reduced mTOR expression, and p70S6K protein expression as well in the lungs of K-ras LA1 mice. However, the protein expression of 4E-BP1 was significantly increased. Such decrease of mTOR and p70S6K proteins and increase of 4E-BP1 were clearly seen in densitometric analysis (Figures 3a and b) . 19 and there was clear association between p53 and Akt-mTOR pathway, 20 we were interested in elucidating the effects of PTEN on some representative proteins important for cell cycle regulation in the lungs of K-ras LA1 mice. Aerosol gene delivery of UAC-PTEN complex significantly increased the formation of p53 and PTEN complex (Figures 4a and  b) , and the nuclear protein levels of both PTEN and p53, however, the protein expressions of pulmonary cytosolic fractions remained unchanged (Figures 4c and d) . Then, we analyzed the protein expressions associated with cell cycle. Recent evidence that p53 plays an important role in cell cycle through controlling p21 and p27 21 prompted to us to measure the protein expressions of p21 and p27. Our result clearly demonstrated that aerosol delivery PTEN significantly decreased the expression of cyclin-dependent kinase 4 (CDK4) through increasing the expression of CDK inhibitors, p27 and p21. The protein expression of cyclin D3 was also significantly suppressed (Figures 4e  and f) by PTEN delivery. In addition, aerosol-delivered PTEN decreased PCNA expression significantly as shown by both IHC (Figure 4g ), and scoring of PCNA labeling index of the immunopositive cells (Figure 4h ).
Discussion
The low efficiency of conventional therapies in achieving long-term survival of patients with lung cancer calls for 22 To overcome such obstacles, numerous attempts have been made for the modification of existing carriers. In the previous works, we reported that modified UAC-DNA complex enhanced gene delivery activity and aerosol gene delivery with UAC/PDCD4 was compatible with in vivo gene delivery and could be applied as a noninvasive gene therapy. 8 Also, our group reported that single aerosol delivery of PTEN with glucosylated polyethylenimine (GPEI) on the K-ras null mice was sufficient to alter signals important for Akt pathways. PTEN is a tumor suppressor protein with phosphatase activity frequently altered in several types of human cancers and can directly inactivate Akt/protein kinase B. 24 Moreover, Akt is a crucial mediator in the signaling pathway, leading to cell survival and cell proliferation, and requires phosphorylation of Thr308 and Ser473 for full activity. 16 In fact, our results showed that PTEN delivery induced overexpression of PTEN and suppressed Akt activity through selective alteration of Akt phosphorylation at Ser473 (Figures 2a and b) . Such selective suppression of Akt activity closely associated with PTEN overexpression may play a key role in suppressing the lung cancer growth in this study (summary in Table 1 and Figure 1 ). In fact, our finding is strongly supported by a recent study that reports that phospho-Akt and PTEN are involved with cancer cell invasion and metastasis and loss of PTEN and therefore is a poor prognostic factor in the patients with non-small cell lung cancer. 25 Moreover, PTEN is known to prevent p53 degradation and to increase p53 transcriptional activity by formation of a complex with p53 in nucleus. 26 Our finding also demonstrated that repeated aerosol delivery of UAC-PTEN complex induced nuclear distribution of p53 (Figures 4a-d) . Together, PTEN-mediated localization of p53 into nucleus and subsequent complex formation with PTEN may be partly responsible for lung tumor suppression in current study.
Akt1 is an upstream regulator of mTOR, and is known to phosphorylate mTOR directly. 27 Loss of PTEN also activates the mTOR pathway and therefore increases protein biosynthesis and cell size. 28, 29 A wide body of evidences supports the role of mTOR in cell signaling related to cell growth and proliferation. 27 Our result showed that Akt/mTOR-mediated signals were significantly decreased by repeated delivery of PTEN in lungs of K-ras LA1 mice (Figures 3a and b) . Kim et al. 23 also reported that aerosol delivery of PTEN could suppress Akt activity, mTOR, and p70S6K protein expression in K-ras null mice. Our results, combined with other evidences, suggest that overexpressed PTEN-mediated suppression of Akt-related signals may also be responsible for tumor suppression in the lungs of K-ras LA1 lung cancer mouse model.
The mTOR also controls cell cycle progression through two main target of its cell growth effectors S6K1 and translation inhibitor 4E-BP1. 30, 31 Rapamycin, an inhibitor of mTOR, may induce cell cycle arrest through inhibition of mTOR-p70S6K signaling and cyclin D3 expression. 32 In the present study, we observed the decreased expressions of cyclin D3, CDK4 and PCNA, and increased expressions of cell cycle inhibitor p27 and p21 in the PTEN delivery lungs (Figure 4) . Several recent studies 33, 34 have reported that PTEN entered into nucleus through passive diffusion is prominent in the G 0 /G 1 segment of cell cycle. According to Freeman et al. 26 and Su et al. 35 p53 in the complex with PTEN inhibits cell cycle through increasing the CDK inhibitors such as p21 and p27. Taken together, our data suggest that repeated aerosol delivery of PTEN suppressed lung tumor growth through downregulation of the Akt-mTOR-p70S6K signals and cell cycle regulation in a way that is done to suppress abnormal cell growth.
In conclusion, the results of our study strongly suggest that aerosol gene delivery may provide an effective noninvasive model of gene delivery and UAC-mediated PTEN delivery may be effective in targeting the Akt signals and cell cycle regulation for lung cancer prevention as well as treatment.
